First Turn Management, LLC Janux Therapeutics, Inc. Transaction History
First Turn Management, LLC
- $496 Billion
- Q1 2025
A detailed history of First Turn Management, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, First Turn Management, LLC holds 430,163 shares of JANX stock, worth $10.2 Million. This represents 2.34% of its overall portfolio holdings.
Number of Shares
430,163
Previous 383,602
12.14%
Holding current value
$10.2 Million
Previous $20.5 Billion
43.45%
% of portfolio
2.34%
Previous 3.68%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
193Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$264 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$109 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$86.2 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$78.6 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$55.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $983M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...